Edition:
United States

Alembic Pharmaceuticals Ltd (ALEM.NS)

ALEM.NS on National Stock Exchange of India

525.05INR
1:38am EST
Change (% chg)

Rs2.75 (+0.53%)
Prev Close
Rs522.30
Open
Rs530.00
Day's High
Rs530.00
Day's Low
Rs523.20
Volume
7,658
Avg. Vol
64,009
52-wk High
Rs648.00
52-wk Low
Rs469.85

Chart for

About

Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The Company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal,... (more)

Overall

Beta: 0.37
Market Cap(Mil.): Rs94,710.40
Shares Outstanding(Mil.): 188.52
Dividend: 4.00
Yield (%): 0.80

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Alembic Pharma Gets U.S. FDA Nod For Generic Drug to Treat Overactive Bladder

* DRUG IS INTENDED TO TREAT OVERACTIVE BLADDER Source text: http://bit.ly/2BVyJWK Further company coverage:

Dec 12 2017

BRIEF-India's Alembic Pharma Sept-qtr consol PAT rises

* Says U.S. formulations business continues to face price erosion on some key products; India branded business showing signs of recovery‍​‍​

Nov 07 2017

BRIEF-Alembic Pharma buys generic drug developer Orit Laboratories

* Says ‍co buys U.S. based generic drug developer Orit Laboratories LLC​ Source text: http://bit.ly/2z3AKCI Further company coverage:

Oct 31 2017

BRIEF-Alembic Pharmaceuticals gets EU GMP certificate for audit conducted at Panelav

* Alembic Pharmaceuticals - gets EU GMP certificate for audit conducted at its formulation facility at Panelav from 8th to 10th Aug Source text for Eikon: Further company coverage:

Aug 31 2017

BRIEF-Alembic Pharma Ltd says sold Baddi plant to Scott Edil Pharmacia Ltd

* Says sold Baddi, Solan plant to Scott Edil Pharmacia Ltd on slump sale basis

Aug 23 2017

BRIEF-Alembic Pharmaceuticals sells formulations manufacturing facility at Baddi to Scott Edil Pharmacia

* Alembic pharmaceuticals says sold on slump sale basis its formulations manufacturing facility at Baddi, dist. Solan to Scott Edil Pharmacia Limited Source text for Eikon: Further company coverage:

Aug 23 2017

BRIEF-India's Alembic Pharmaceuticals says fire at Algerian JV plant

* Says there was a fire incident at Algerian joint venture plant at Constantine, Algeria Constantine, Algeria

Aug 18 2017

BRIEF-Alembic Pharmaceuticals gets U.S. FDA approval for Doxycycline Capsules USP, 75 mg & 100 mg

* Says Alembic Pharmaceuticals Limited receives USFDA approval for Doxycycline Capsules USP, 75 mg and 100 Mg.

Jul 31 2017

BRIEF-India's Alembic Pharma June-qtr consol PAT falls

* June quarter consol profit after tax 633.8 million rupees versus 1.04 billion rupees year ago

Jul 20 2017

BRIEF-India's Alembic Pharma gets FDA nod for generic hypertension drug

* Says ‍received U.S. food & drug administration (USFDA) approval for olmesartan medoxomil and amlodipine tablets​ Source text for Eikon: Further company coverage:

Jul 18 2017

Earnings vs. Estimates